Partnering Solutions
-
Clinical Excellence – From Molecule To Milestone
9/23/2026
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.
-
TrialKit For Patient Registry Studies
7/2/2024
TrialKit requires minimal training for quick deployment. Its open API integrates seamlessly with databases, ideal for fast patient registry studies and high-quality data.
-
Our Technology
12/5/2025
Built From The Ground Up
Block Clinical understood from the beginning that intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.
-
Cell And Gene Therapies
4/28/2021
Accelerate your cell or gene therapeutic to market with tailored clinical and regulatory strategies and expert insights.
-
Supporting Early Phase Research Through Collaboration
8/5/2026
Early phase trials demand speed and precision. Discover a partnership providing specialized expertise that keeps your program on track.
-
Drug-Drug Interaction (DDI) Studies
10/16/2023
Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.
-
Why IQVIA Participant Payments?
10/30/2024
Learn about how this participant-friendly technology ensures efficient and secure payments, enhancing the clinical trial experience for all involved.
-
Speed, Precision, Impact: The CRO Revolutionizing Bioanalysis
9/8/2025
Move drug development into the modern era with a CRO that offers assay development and validation, bioanalytical testing, sample prep, and more.
-
An FSP Model Can Minimize The Risks Of Failure And Missed Milestones
3/27/2023
Specialized, demand-driven resourcing from Veristat ensures a clinical team’s focus remains where it should be: meeting study milestones and accelerating time to market.
-
Why Fee-Free Trial Participant Payments Always Pay Off
8/25/2025
Remove the administrative burden of clinical trials for patients while ensuring compliance and offering global accessibility.